Continuing Oral Anticoagulants After ≥90 Days Tied to Lower Risk for Recurrent VTE

THURSDAY, Nov. 20, 2025-- For adults with venous thromboembolism (VTE), continuing oral anticoagulants (OAC) after initial anticoagulation of at least 90 days is associated with a lower risk for recurrent VTE and a net clinical benefit, according...